Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) directed therapy of patients with malignant pleural effusion and pleural metastasis

Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) directed therapy of patients with malignant pleural effusion and pleural metastasis

Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) has been suggested as a new therapy for patients with malignant pleural effusion (MPE) and/or pleural metastasis (PLM). The patients have a poor prognosis with a median survival of 3 to 12 months. We present feasibility, patient safety, and cyto...

Full description

Bibliographic Details
Main Authors: Hansen Pernille Schjødt, Graversen Martin, Detlefsen Sönke, Ainsworth Alan Patrick, Mortensen Michael Bau
Format: Article
Language:English
Published: De Gruyter 2024-11-01
Series:Pleura and Peritoneum
Subjects:
malignant pleural effusion
pleural metastasis
palliative treatment
thoracic regression grading score (trgs)
pressurized intrathoracic aerosol chemotherapy (pitac)
Online Access:https://doi.org/10.1515/pp-2024-0008

Internet

https://doi.org/10.1515/pp-2024-0008

Similar Items